Amphenol Corporation
—- Market cap
- $98.95B
- Debt
- —
- Cash
- −$11.13B
Complete market value, debt and cash evidence is required for enterprise value.
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: APH stock price vs VSH: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at VSH's multiple
Needs VSH P/E.
Implied fair value · at APH's multiple
Needs Annual EPS is negative.
Snapshot Sep 10, 2026, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Reported gross margin
Operating income + D&A
Lower is better
Not comparable
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
Eight period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Complete market value, debt and cash evidence is required for enterprise value.
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
AMPHENOL CORPORATION · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Vishay Intertechnology, Inc. · implied price per share
Latest annual free cash flow must be positive to qualify the filing-backed baseline.
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
TE Connectivity plc
APH vs TEL
CORNING INC /NY
APH vs GLW
CommScope Holding Company, Inc.
APH vs COMM
HUBBELL INC
APH vs HUBB
BEL FUSE INC /NJ
APH vs BELFA
TEXAS INSTRUMENTS INC
APH vs TXN
ANALOG DEVICES INC
APH vs ADI
INTEL CORP
APH vs INTC
MICROCHIP TECHNOLOGY INC
APH vs MCHP
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe APH can sustain its exceptional growth and 25.4% operating margin without mean reversion, then hold or accumulate on weakness because the business quality is clearly superior to VSH; otherwise, the current multiple looks hard to justify versus VSH-implied and DCF ranges.
The valuation gap is extreme: APH trades at 8.6x P/S versus VSH at 1.5x, while VSH-implied price is only $27.47, implying -82.9% downside from the current $160.70. Although APH deserves a premium for stronger profitability and growth, the current price also sits above the top of VSH implied range and below the historical band midpoint only if you anchor to APH’s own long-run trading range.
Supporting Metrics